Diagnostic Accuracy of Doppler Resistive Indices for Early Diagnosis of Acute Kidney Injury .
NCT ID: NCT02580292
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2015-10-31
2024-04-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Renal Resistive Index in Early Detection of Postoperative Acute Kidney Injury
NCT06791304
Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery
NCT02831907
RDRI and NGAL in Acute Kidney Injury in Abdominal Surgery
NCT05929573
Urine Adiponectin Concentration in Prediction of Contrast Induced Nephropathy
NCT01372891
Carotid Doppler and IVC Measurements for Volume Guided Management in Acute Kidney Injury Patients
NCT05938049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing cardiac surgery with cardiopulmonary bypass and transesophageal echocardiography (TEE) probe placement
Exclusion Criteria
* prior carotid endarterectomy
* known carotid artery stenosis of 50% or greater
* dissection or aneurysm involving renal or carotid arteries
* scheduled aortic or aortic valve surgery
* heart transplant
* intraaortic balloon pump, ventricular assist device, or exctracorporeal membrane oxygenation support.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Milo Engoren
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Milo Engoren
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular Center - University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.